Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

Leithner, A; Schnack, B; Katterschafka, T; Wiltschke, C; Amann, G; Windhager, R; Kotz, R; Zielinski, CC.
Treatment of extra-abdominal desmoid tumors with interferon-alpha with or without tretinoin.
J Surg Oncol. 2000; 73(1):21-25 Doi: 10.1002%2F%28SICI%291096-9098%28200001%2973%3A1%3C21%3A%3AAID-JSO6%3E3.0.CO%3B2-G
Web of Science PubMed FullText FullText_MUG

 

Führende Autor*innen der Med Uni Graz
Leithner Andreas
Co-Autor*innen der Med Uni Graz
Windhager Reinhard
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
BACKGROUND AND OBJECTIVES: Surgery is the main treatment for extra-abdominal desmoid tumors, but the results of further management remain uncertain. Therefore, a retrospective analysis was undertaken to evaluate the toxicity and efficacy of treatment with interferon-alpha (IFN-alpha) +/- tretinoin in this setting. METHODS: Thirteen patients with extra-abdominal desmoid tumors and a median age of 32 years (range, 15-73) received IFN-alpha. Seven of these patients received a combination of IFN-alpha and tretinoin in order to test further enhancement. RESULTS: After a mean observation period of 27 +/- 15 months (mean +/- standard deviation) under treatment with IFN-alpha +/- tretinoin, local control was seen in 11 of 13 patients (85%). Seven patients had no evidence of disease at a mean disease-free interval of 22 +/- 18 months; in two patients progressive disease occurred after only 7 and 9 months, respectively, of observation. In another four patients, progression of the desmoid tumor was stabilized. CONCLUSIONS: The data of this retrospective, nonrandomized study on therapy with IFN-alpha +/- tretinoin suggest that such treatment may be effective in prolonging the disease-free interval of patients after intralesional or marginal surgery. Because of the encouraging response rate, this regimen appears to be another nonsurgical treatment alternative.
Find related publications in this database (using NLM MeSH Indexing)
Adolescent -
Adult -
Aged -
Antineoplastic Agents - administration and dosage
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Chemotherapy, Adjuvant - therapeutic use
Disease Progression - therapeutic use
Disease-Free Survival - therapeutic use
Female - therapeutic use
Fibromatosis, Aggressive - drug therapy
Follow-Up Studies - drug therapy
Humans - drug therapy
Interferon-alpha - administration and dosage
Male - administration and dosage
Middle Aged - administration and dosage
Neoplasm Recurrence, Local - drug therapy
Retrospective Studies - drug therapy
Survival Rate - drug therapy
Tretinoin - administration and dosage

Find related publications in this database (Keywords)
desmoids
aggressive fibromatosis
systemic therapy
nonsurgical treatment
© Med Uni Graz Impressum